Skip Ribbon Commands
Skip to main content





Hon Mrs Kalpana Devi KOONJOO-SHAH​ 
Minister of Gender Equality and Family Welfare​

​2002-2005​                 University of Brighton, United Kingdom
                                  BSc (Hons) Biological Sciences
                                  Thesis study/specialisation: Thesis: Infectious Diseases in Developing Countries​
​2000- 2002                University of Brighton, United Kingdom
​January 2017 –         Ministry of Health and Quality of Life Mauritius
October 2017            Assistant Permanent Secretary (Procurement)
​October 2013 –         Avacare Health International Mauritius
October 2014            Regulatory Officer
                                  Development, post- approval and Life cycle management of Drug Products, Consumables  and Disposables
​January 2013-           VWR International LLC. Mauritius
31st May 2013          EU Regulatory Affairs Associate
                                  Responsible for assessment of regulatory requirements for a wide range of laboratory                                                                                                                                                  equipment,medical devices and APIs (REACh, CE, RoHS, GCP, GDP, GMP, eCTD).
​November 2011 –     Aspen Global Incorporated Mauritius
November 2012        Pharmaceutical Affairs Consultant
                                  Complete and maintain the Technical Terms of Supply per manufacturing site per product
​May 2008 –               BG Group Plc United Kingdom
May 2011                  Production Chemistry SME
                                  Compiling the daily drilling reports, summaries, casing tally, casing cement report, BHA   record.                                                                                                           
​August 2005 –​           University Hospital Birmingham NHS Foundation Trust (Selly Oak) United Kingdom
January 2008            Regulatory Advisor
                                  Maintenance of existing MAAs as required and liaise with external regulatory authorities  (GCP, MHRA etc)